9 results on '"Torihara H"'
Search Results
2. Simultaneous measurement of nascent transcriptome and translatome using 4-thiouridine metabolic RNA labeling and translating ribosome affinity purification.
- Author
-
Imai H, Utsumi D, Torihara H, Takahashi K, Kuroyanagi H, and Yamashita A
- Subjects
- Animals, Mammals genetics, Ribosome Profiling, Ribosomes genetics, Ribosomes metabolism, RNA metabolism, Gene Expression Regulation, Protein Biosynthesis, Thiouridine, Transcriptome, Genetic Techniques
- Abstract
Regulation of gene expression in response to various biological processes, including extracellular stimulation and environmental adaptation requires nascent RNA synthesis and translation. Analysis of the coordinated regulation of dynamic RNA synthesis and translation is required to determine functional protein production. However, reliable methods for the simultaneous measurement of nascent RNA synthesis and translation at the gene level are limited. Here, we developed a novel method for the simultaneous assessment of nascent RNA synthesis and translation by combining 4-thiouridine (4sU) metabolic RNA labeling and translating ribosome affinity purification (TRAP) using a monoclonal antibody against evolutionarily conserved ribosomal P-stalk proteins. The P-stalk-mediated TRAP (P-TRAP) technique recovered endogenous translating ribosomes, allowing easy translatome analysis of various eukaryotes. We validated this method in mammalian cells by demonstrating that acute unfolded protein response (UPR) in the endoplasmic reticulum (ER) induces dynamic reprogramming of nascent RNA synthesis and translation. Our nascent P-TRAP (nP-TRAP) method may serve as a simple and powerful tool for analyzing the coordinated regulation of transcription and translation of individual genes in various eukaryotes., (© The Author(s) 2023. Published by Oxford University Press on behalf of Nucleic Acids Research.)
- Published
- 2023
- Full Text
- View/download PDF
3. Roles of Pyk2 in signal transduction after gonadotropin-releasing hormone receptor stimulation.
- Author
-
Okitsu-Sakurayama S, Higa-Nakamine S, Torihara H, Higashiyama S, and Yamamoto H
- Subjects
- Animals, Cell Line, Enzyme Activation drug effects, Epidermal Growth Factor metabolism, ErbB Receptors metabolism, GRB2 Adaptor Protein metabolism, Gonadotropin-Releasing Hormone pharmacology, MAP Kinase Signaling System drug effects, Mice, Models, Biological, Protein Binding drug effects, RNA, Small Interfering metabolism, Transcriptional Activation drug effects, raf Kinases metabolism, Focal Adhesion Kinase 2 metabolism, Receptors, LHRH metabolism, Signal Transduction drug effects
- Abstract
The receptor for gonadotropin-releasing hormone (GnRH) is highly expressed in hypothalamic neurons. It has been reported that GnRH treatment of cultured GnRH neurons (GT1-7 cells) activated proline-rich tyrosine kinase 2 (Pyk2), and Pyk2 was involved in the activation of extracellular signal-regulated protein kinase 1 (ERK1) and ERK2 (ERK1/2). In the present study, we first examined the possibility that GnRH treatment might activate epidermal growth factor receptor (EGFR). We found that activation of EGFR after GnRH treatment for 5 min was much less than after EGF or heparin-binding EGF treatment. Next, we examined whether or not Pyk2 bound to growth factor receptor-binding protein 2 (Grb2). We overexpressed FLAG-fused Pyk2 in GT1-7 cells, and immunoprecipitated Pyk2 using an anti-FLAG antibody. The binding of Pyk2 to Grb2 was detected only after GnRH treatment. In contrast, a site-directed mutant of Pyk2 wherein tyrosine 881 was mutated to phenylalanine did not bind to Grb2. Studies with small interfering RNA and inhibitors indicated that the activation of Grb2/Ras/Raf/MEK was a major pathway to ERK1/2 activation after the short-term treatment of GT1-7 cells with GnRH., (© 2020 Wiley Periodicals LLC.)
- Published
- 2021
- Full Text
- View/download PDF
4. Activation of Pyk2 by CaM kinase II in cultured hypothalamic neurons and gonadotroph cells.
- Author
-
Okitsu-Sakurayama S, Higa-Nakamine S, Torihara H, Takahashi H, Higashiyama S, and Yamamoto H
- Subjects
- Animals, Cell Line, Enzyme Activation physiology, Extracellular Signal-Regulated MAP Kinases metabolism, Gonadotropin-Releasing Hormone metabolism, MAP Kinase Signaling System physiology, Mice, Receptors, LHRH metabolism, Signal Transduction physiology, Calcium-Calmodulin-Dependent Protein Kinase Type 2 metabolism, Focal Adhesion Kinase 2 metabolism, Gonadotrophs metabolism, Hypothalamus metabolism, Neurons metabolism
- Abstract
Gonadotropin-releasing hormone (GnRH) is secreted from hypothalamic GnRH neurons and stimulates a GnRH receptor in gonadotroph cells and GnRH neurons. The GnRH receptor belongs to the G-protein-coupled receptors, and stimulation of the GnRH receptor activates extracellular signal-regulated protein kinase (ERK). We reported previously that the δ2 isoform of Ca
2+ /calmodulin-dependent protein kinase II (CaM kinase IIδ2) was involved in GnRH-induced ERK activation in cultured GnRH neurons (GT1-7 cells). Recently, we found that GnRH treatment of GT1-7 cells activated proline-rich tyrosine kinase 2 (Pyk2), and Pyk2 was involved in ERK activation. In the current study, we examined the possibility that CaM kinase IIδ2 might activate Pyk2. Knockdown of CaM kinase IIδ2 and KN93, an inhibitor of CaM kinases, inhibited the GnRH-induced activation of Pyk2. In the case of cultured gonadotroph cells (αT3-1 cells), knockdown of CaM kinase IIβ'e inhibited GnRH-induced Pyk2 activation. In addition, our inhibitor studies indicated that Pyk2 and CaM kinase II were involved in the GnRH-induced shedding of proHB-EGF in GT1-7 cells. These results suggested that CaM kinase II activated the ERK pathway through Pyk2 activation and HB-EGF production in response to GnRH., (© 2018 Wiley Periodicals, Inc.)- Published
- 2019
- Full Text
- View/download PDF
5. Phosphorylation of epidermal growth factor receptor at serine 1047 in cultured lung alveolar epithelial cells by bradykinin B2 receptor stimulation.
- Author
-
Izumi S, Higa-Nakamine S, Nishi H, Torihara H, Uehara A, Sugahara K, Kakinohana M, and Yamamoto H
- Subjects
- A549 Cells, Animals, Cell Line, Dual-Specificity Phosphatases genetics, Humans, Lung cytology, Lung metabolism, Mice, Mitogen-Activated Protein Kinases metabolism, Phosphorylation, RNA, Messenger metabolism, Tumor Necrosis Factor-alpha metabolism, p38 Mitogen-Activated Protein Kinases metabolism, Alveolar Epithelial Cells metabolism, Bradykinin pharmacology, ErbB Receptors metabolism, Receptor, Bradykinin B2 metabolism
- Abstract
Accumulating evidence indicates that epidermal growth factor receptor (EGFR) is desensitized by phosphorylation of serine 1047 (Ser1047). We and other groups have reported that stimulation of a receptor of tumor-necrosis factor α (TNFα) and Toll-like receptor 5 (TLR5) induced the phosphorylation of Ser1047 through activation of p38 mitogen-activated protein kinase (p38 MAPK) in cultured lung alveolar epithelial A549 cells. However, phosphorylation of EGFR at Ser1047 by stimulation of any G-protein coupled receptors (GPCRs) has not been reported in any cultured cells. In the present study, we first confirmed that A549 cells expressed bradykinin (BK) B2 receptor, and then, we examined whether BK treatment of A549 cells activated MAPKs and induced the phosphorylation of EGFR at Ser1047. Immunoblotting analysis and reporter gene assays indicated that BK activated the pathways of extracellular signal-regulated kinase (ERK) and p38 MAPK. Inhibitor studies suggested that G
q/11 was mainly involved in the activation of ERK and p38 MAPK. We found that stimulation of the BK B2 receptor, but not the BK B1 receptor, induced phosphorylation of EGFR at Ser1047. Pharmacological experiments indicated that both ERK and p38 MAPK were involved in the phosphorylation of EGFR. These results strongly suggested that BK regulates EGFR functions in lung alveolar epithelial cells. In addition, we found that BK treatment increased the mRNA level of dual specificity MAPK phosphatase 5 (DUSP5) in an ERK-dependent manner, which suggested that a negative feedback mechanism of ERK existed in the cells., (Copyright © 2017 Elsevier Ltd. All rights reserved.)- Published
- 2018
- Full Text
- View/download PDF
6. Erythropoiesis failure due to RPS19 deficiency is independent of an activated Tp53 response in a zebrafish model of Diamond-Blackfan anaemia.
- Author
-
Torihara H, Uechi T, Chakraborty A, Shinya M, Sakai N, and Kenmochi N
- Subjects
- Anemia, Diamond-Blackfan genetics, Anemia, Diamond-Blackfan metabolism, Anemia, Diamond-Blackfan pathology, Animals, Apoptosis, Disease Models, Animal, Genes, p53, RNA, Messenger genetics, Ribosomal Proteins genetics, Tumor Suppressor Protein p53 deficiency, Zebrafish, Anemia, Diamond-Blackfan physiopathology, Erythropoiesis physiology, Ribosomal Proteins deficiency, Tumor Suppressor Protein p53 physiology
- Abstract
Diamond-Blackfan anaemia (DBA) is a cancer-prone genetic disorder characterized by pure red-cell aplasia and associated physical deformities. The ribosomal protein S19 gene (RPS19) is the most frequently mutated gene in DBA (~25%). TP53-mediated cell cycle arrest and/or apoptosis in erythroid cells have been suggested to be major factors for DBA development, but it is not clear why mutations in the ubiquitously expressed RPS19 gene specifically affect erythropoiesis. Previously, we showed that RPS19 deficiency in zebrafish recapitulates the erythropoietic and developmental phenotypes of DBA, including defective erythropoiesis with severe anaemia. In this study, we analysed the simultaneous loss-of-function of RPS19 and Tp53 in zebrafish to investigate the role of Tp53 in the erythroid and morphological defects associated with RPS19 deficiency. Co-inhibition of Tp53 activity rescued the morphological abnormalities, but did not alleviate erythroid aplasia in RPS19-deficient zebrafish. In addition, knockdown of two other RP genes, rps3a and rpl36a, which result in severe morphological abnormalities but only mild erythroid defects, also elicited an activated Tp53 response. These results suggest that a Tp53-independent but RPS19-dependent pathway could be responsible for defective erythropoiesis in RPS19-deficient zebrafish., (© 2011 Blackwell Publishing Ltd.)
- Published
- 2011
- Full Text
- View/download PDF
7. Loss of ribosomal protein L11 affects zebrafish embryonic development through a p53-dependent apoptotic response.
- Author
-
Chakraborty A, Uechi T, Higa S, Torihara H, and Kenmochi N
- Subjects
- Animals, Animals, Genetically Modified, Embryo, Nonmammalian metabolism, Embryonic Development genetics, Neurons metabolism, RNA, Messenger metabolism, Signal Transduction, Transcription Factors genetics, Transcription Factors metabolism, Tumor Suppressor Protein p53 metabolism, Zebrafish metabolism, Zebrafish Proteins metabolism, Apoptosis genetics, Ribosomal Proteins genetics, Tumor Suppressor Protein p53 genetics, Zebrafish embryology, Zebrafish genetics, Zebrafish Proteins genetics
- Abstract
Ribosome is responsible for protein synthesis in all organisms and ribosomal proteins (RPs) play important roles in the formation of a functional ribosome. L11 was recently shown to regulate p53 activity through a direct binding with MDM2 and abrogating the MDM2-induced p53 degradation in response to ribosomal stress. However, the studies were performed in cell lines and the significance of this tumor suppressor function of L11 has yet to be explored in animal models. To investigate the effects of the deletion of L11 and its physiological relevance to p53 activity, we knocked down the rpl11 gene in zebrafish and analyzed the p53 response. Contrary to the cell line-based results, our data indicate that an L11 deficiency in a model organism activates the p53 pathway. The L11-deficient embryos (morphants) displayed developmental abnormalities primarily in the brain, leading to embryonic lethality within 6-7 days post fertilization. Extensive apoptosis was observed in the head region of the morphants, thus correlating the morphological defects with apparent cell death. A decrease in total abundance of genes involved in neural patterning of the brain was observed in the morphants, suggesting a reduction in neural progenitor cells. Upregulation of the genes involved in the p53 pathway were observed in the morphants. Simultaneous knockdown of the p53 gene rescued the developmental defects and apoptosis in the morphants. These results suggest that ribosomal dysfunction due to the loss of L11 activates a p53-dependent checkpoint response to prevent improper embryonic development.
- Published
- 2009
- Full Text
- View/download PDF
8. Deficiency of ribosomal protein S19 during early embryogenesis leads to reduction of erythrocytes in a zebrafish model of Diamond-Blackfan anemia.
- Author
-
Uechi T, Nakajima Y, Chakraborty A, Torihara H, Higa S, and Kenmochi N
- Subjects
- Anemia, Diamond-Blackfan genetics, Animals, Base Sequence, DNA Primers genetics, Disease Models, Animal, Erythropoiesis genetics, Gene Targeting, Humans, Mutation, Phenotype, RNA, Antisense genetics, RNA, Messenger biosynthesis, RNA, Messenger genetics, Ribosomal Proteins blood, Ribosomal Proteins genetics, Zebrafish genetics, Zebrafish Proteins blood, Anemia, Diamond-Blackfan blood, Anemia, Diamond-Blackfan embryology, Ribosomal Proteins deficiency, Zebrafish blood, Zebrafish embryology, Zebrafish Proteins deficiency, Zebrafish Proteins genetics
- Abstract
Ribosomes are responsible for protein synthesis in all cells. Ribosomal protein S19 (RPS19) is one of the 79 ribosomal proteins (RPs) in vertebrates. Heterozygous mutations in RPS19 have been identified in 25% of patients with Diamond-Blackfan anemia (DBA), but the relationship between RPS19 mutations and the pure red-cell aplasia of DBA is unclear. In this study, we developed an RPS19-deficient zebrafish by knocking down rps19 using a Morpholino antisense oligo. The RPS19-deficient animals showed a dramatic decrease in blood cells as well as deformities in the head and tail regions at early developmental stages. These phenotypes were rescued by injection of zebrafish rps19 mRNA, but not by injection of rps19 mRNAs with mutations that have been identified in DBA patients. Our results indicate that rps19 is essential for hematopoietic differentiation during early embryogenesis. The effects were specific to rps19, but knocking down the genes for three other RPs, rpl35, rpl35a and rplp2, produced similar phenotypes, suggesting that these genes might have a common function in zebrafish erythropoiesis. The RPS19-deficient zebrafish will provide a valuable tool for investigating the molecular mechanisms of DBA development in humans.
- Published
- 2008
- Full Text
- View/download PDF
9. Ribosomal protein gene knockdown causes developmental defects in zebrafish.
- Author
-
Uechi T, Nakajima Y, Nakao A, Torihara H, Chakraborty A, Inoue K, and Kenmochi N
- Subjects
- Animals, Animals, Genetically Modified, Base Sequence, Brain abnormalities, Disease Models, Animal, Gene Targeting, Humans, Mutagenesis, Insertional, Mutation, Oligodeoxyribonucleotides, Antisense genetics, Phenotype, Ribosomal Proteins antagonists & inhibitors, Zebrafish Proteins antagonists & inhibitors, Ribosomal Proteins deficiency, Ribosomal Proteins genetics, Zebrafish embryology, Zebrafish genetics, Zebrafish Proteins deficiency, Zebrafish Proteins genetics
- Abstract
The ribosomal proteins (RPs) form the majority of cellular proteins and are mandatory for cellular growth. RP genes have been linked, either directly or indirectly, to various diseases in humans. Mutations in RP genes are also associated with tissue-specific phenotypes, suggesting a possible role in organ development during early embryogenesis. However, it is not yet known how mutations in a particular RP gene result in specific cellular changes, or how RP genes might contribute to human diseases. The development of animal models with defects in RP genes will be essential for studying these questions. In this study, we knocked down 21 RP genes in zebrafish by using morpholino antisense oligos to inhibit their translation. Of these 21, knockdown of 19 RPs resulted in the development of morphants with obvious deformities. Although mutations in RP genes, like other housekeeping genes, would be expected to result in nonspecific developmental defects with widespread phenotypes, we found that knockdown of some RP genes resulted in phenotypes specific to each gene, with varying degrees of abnormality in the brain, body trunk, eyes, and ears at about 25 hours post fertilization. We focused further on the organogenesis of the brain. Each knocked-down gene that affected the morphogenesis of the brain produced a different pattern of abnormality. Among the 7 RP genes whose knockdown produced severe brain phenotypes, 3 human orthologs are located within chromosomal regions that have been linked to brain-associated diseases, suggesting a possible involvement of RP genes in brain or neurological diseases. The RP gene knockdown system developed in this study could be a powerful tool for studying the roles of ribosomes in human diseases.
- Published
- 2006
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.